Litigation Details for IMMUNEX CORPORATION v. SAMSUNG BIOEPIS CO., LTD. (D.N.J. 2019)
✉ Email this page to a colleague
IMMUNEX CORPORATION v. SAMSUNG BIOEPIS CO., LTD. (D.N.J. 2019)
| Docket | ⤷ Try a Trial | Date Filed | 2019-04-30 |
| Court | District Court, D. New Jersey | Date Terminated | |
| Cause | 35:271 Patent Infringement | Assigned To | Claire Claudia Cecchi |
| Jury Demand | Plaintiff | Referred To | Mark Falk |
| Parties | AMGEN MANUFACTURING, LIMITED; HOFFMANN-LA ROCHE INC.; IMMUNEX CORPORATION; SAMSUNG BIOEPIS CO., LTD.; SANDOZ INC.; SANDOZ GMBH; SANDOZ INTERNATIONAL GMBH | ||
| Patents | 6,235,883; 6,858,409; 7,915,225; RE37,336; RE37,343 | ||
| Attorneys | CHARLES H. CHEVALIER; CHRISTINA LYNN SAVERIANO; CHRISTINE INTROMASSO GANNON; COLLEEN M. MAKER; DAVID E. DELORENZI; JUSTIN TAYLOR QUINN; KEITH J. MILLER; LIZA M. WALSH; MARC D. HAEFNER; SARAH ANN SULLIVAN; WILLIAM C. BATON | ||
| Firms | Christina Lynn Saveriano; Robinson Miller LLC, Ironside Newark | ||
| Link to Docket | External link to docket | ||
Biologic Drugs cited in IMMUNEX CORPORATION v. SAMSUNG BIOEPIS CO., LTD.
The biologic drugs covered by the patents cited in this case are ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , ⤷ Try a Trial , and ⤷ Try a Trial .
Details for IMMUNEX CORPORATION v. SAMSUNG BIOEPIS CO., LTD. (D.N.J. 2019)
| Date Filed | Document No. | Description | Snippet | Link To Document |
|---|---|---|---|---|
| 2019-04-30 | 1 | Complaint | “Roche Patents”); and • U.S. Patents Nos. 7,915,225 (“the ’225 Patent”), 8,119,605…United States Patent Nos. 8,063,182 (“the ’182 Patent”), 8,163,522 (“the ’522 Patent”), 7,915,225 (“the ’225…arthritis. The ’225 Patent, the ’605 Patent, and the ’631 Patent (“the Immunex Patents”), owned by Immunex…States Patent Nos. 8,063,182 (“the ’182 Patent”) and 8,163,522 (“the ’522 Patent”) (collectively… Patent”), and 8,722,631 (“the ’631 Patent”) (collectively, “the Immunex Patents”). | External link to document |
| 2019-12-23 | 107 | Amended Complaint | control element Such as, for U.S. Pat. No. 6,235,883 B1. Human antibodies can also be … 18 those described in U.S. Pat. No. 6,235,883 B1, incorporated encoding the human… U.S. Patent No. 8,063,182 (“the ’182 Patent”), • U.S. Patent No. 8,163,…Roche Patents”), • U.S. Patent No. 6,872,549 (“the ’549 Patent”), … U.S. Patent No. 6,924,124 (“the ’124 Patent”), • U.S. Patent No. 7,157, | External link to document |
| >Date Filed | >Document No. | >Description | >Snippet | >Link To Document |
